Abbott’s heart defect treatment device for babies gets FDA approval

PDA is a common congenital cardiac defect that is characterised by an opening between two blood vessels leading from the heart, resulting in difficulty in breathing.

Of the 60,000 premature babies born each year in the US, approximately 12,000 have a haemodynamically significant PDA requiring urgent medical intervention.

The new minimally invasive, transcatheter is said to be specifically intended to treat premature babies and newborns with PDA.